21st Sep 2018 11:47
LONDON (Alliance News) - OKYO Pharma Ltd on Friday said it appointed Raj Patil as senior director of Research & Development.
The biotechnology company said Patil is not assuming a position on the board of directors. Instead, Patil will focus on the non-clinical development of lead compounds through to investigational new drug submission for dry eye disease.
Patil will also lead non-clinical development of OKYO Pharma's lead first-in-class drug candidates, it said.
Before joining OKYO Pharma, Patil worked at iVeena as vice president for Advanced Ocular Delivery Systems.
"OKYO Pharma is fully committed to developing and growing our pipeline to treat vision impairing disorders and a non-opioid based therapy for chronic pain management," said Chairman Willy Simon.
"To achieve this the board recognises the need to attract top talent, such as Patil," Simon added.
Shares in OKYO Pharma were trading 6.7% higher on Friday at 2.00 pence each.
Related Shares:
OKYO.L